Clinical Trials Directory

Trials / Unknown

UnknownNCT02749656

Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis

A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
105 (estimated)
Sponsor
Siriraj Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream (Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp psoriasis.

Conditions

Interventions

TypeNameDescription
DRUG0.25% Desoximetasone cream (Topoxy®)apply on the scalp psoriasis lesion twice a day
DRUG0.25% Desoximetasone cream (Topicorte®)apply on the scalp psoriasis lesion twice a day
DRUGPlaceboapply on the scalp psoriasis lesion twice a day

Timeline

Start date
2016-01-01
Primary completion
2018-01-01
Completion
2018-12-01
First posted
2016-04-25
Last updated
2017-05-01

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02749656. Inclusion in this directory is not an endorsement.

Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis (NCT02749656) · Clinical Trials Directory